QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)
QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)
QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)
QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$407.29
+2.1%
$400.30
$274.98
$670.00
$716.83M0.616,762 shs15,433 shs
Haemonetics Co. stock logo
HAE
Haemonetics
$84.59
-0.3%
$78.72
$70.74
$95.26
$4.30B0.36441,088 shs505,857 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$96.28
+0.4%
$102.46
$78.28
$212.43
$2.35B0.69257,734 shs52,150 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$71.10
-0.6%
$75.41
$62.58
$85.62
$4.13B0.89497,379 shs66,537 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
-2.53%-6.74%-7.74%+20.11%-33.52%
Haemonetics Co. stock logo
HAE
Haemonetics
+0.80%-1.50%+11.98%+1.65%-0.14%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-0.47%-3.95%-3.32%+0.65%-45.05%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
-1.70%-0.61%-0.96%-8.92%-5.98%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
1.5007 of 5 stars
0.01.02.50.02.43.31.3
Haemonetics Co. stock logo
HAE
Haemonetics
3.952 of 5 stars
2.34.00.04.32.31.71.9
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.4939 of 5 stars
3.53.00.03.92.52.51.9
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
4.9386 of 5 stars
4.44.00.03.82.82.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
2.50
Moderate Buy$104.6723.73% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0027.75% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.89
Moderate Buy$92.5030.10% Upside

Current Analyst Ratings

Latest HAE, ICUI, MMSI, and ATRI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$98.00
4/12/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
4/11/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$88.00
4/11/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$88.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$82.00 ➝ $87.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$81.00 ➝ $88.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$96.00 ➝ $98.00
2/29/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$102.00 ➝ $112.00
2/28/2024
ICU Medical, Inc. stock logo
ICUI
ICU Medical
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$134.00 ➝ $136.00
2/13/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
2/7/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$87.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$169.33M4.23$19.52 per share20.86$138.02 per share2.95
Haemonetics Co. stock logo
HAE
Haemonetics
$1.17B3.68$5.00 per share16.92$16.22 per share5.22
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.04$15.31 per share6.29$87.96 per share1.09
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.26B3.28$4.72 per share15.07$20.81 per share3.42

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$11.0336.93N/A11.46%8.07%7.37%5/13/2024 (Estimated)
Haemonetics Co. stock logo
HAE
Haemonetics
$115.40M$2.4634.3920.051.999.97%22.37%9.71%5/9/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A17.90N/A-1.31%6.35%3.03%5/13/2024 (Estimated)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$94.41M$1.6243.8919.432.037.51%14.63%9.19%4/30/2024 (Confirmed)

Latest HAE, ICUI, MMSI, and ATRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$0.88N/A-$0.88N/AN/AN/A  
4/30/2024N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.70N/A-$0.70N/AN/AN/A  
2/29/2024Q4 2023
Atrion Co. stock logo
ATRI
Atrion
N/A$3.65+$3.65$3.65N/A$43.58 million
2/28/2024Q4 2023
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.77$0.81+$0.04$1.15$320.66 million$324.52 million    
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/8/202412/31/2023
Haemonetics Co. stock logo
HAE
Haemonetics
$0.94$1.04+$0.10$1.47$320.84 million$336.20 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.802.16%+9.65%79.78%21 Years
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A

Latest HAE, ICUI, MMSI, and ATRI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
Atrion Co. stock logo
ATRI
Atrion
Quarterly$2.202.42%3/14/20243/15/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.09
2.57
Haemonetics Co. stock logo
HAE
Haemonetics
0.91
2.92
1.76
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.68
5.45
3.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.70%
Haemonetics Co. stock logo
HAE
Haemonetics
1.79%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
6.70%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7121.76 million1.36 millionNot Optionable
Haemonetics Co. stock logo
HAE
Haemonetics
3,03450.79 million49.88 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
6,95058.06 million55.92 millionOptionable

HAE, ICUI, MMSI, and ATRI Headlines

SourceHeadline
Louisiana State Employees Retirement System Acquires New Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)Louisiana State Employees Retirement System Acquires New Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)
marketbeat.com - April 18 at 5:56 AM
Merit Medical Systems (NASDAQ:MMSI) Receives Outperform Rating from Barrington ResearchMerit Medical Systems (NASDAQ:MMSI) Receives Outperform Rating from Barrington Research
americanbankingnews.com - April 17 at 4:14 AM
Outperform Rating Maintained for Merit Medical Systems Amid Strong Growth and Profitability ProjectionsOutperform Rating Maintained for Merit Medical Systems Amid Strong Growth and Profitability Projections
markets.businessinsider.com - April 16 at 6:26 PM
Merit Medical Systems (NASDAQ:MMSI) Receives "Outperform" Rating from Barrington ResearchMerit Medical Systems (NASDAQ:MMSI) Receives "Outperform" Rating from Barrington Research
marketbeat.com - April 16 at 11:21 AM
SG Americas Securities LLC Cuts Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)SG Americas Securities LLC Cuts Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)
marketbeat.com - April 16 at 4:07 AM
Merit Medical Systems (NASDAQ:MMSI) Downgraded by StockNews.comMerit Medical Systems (NASDAQ:MMSI) Downgraded by StockNews.com
americanbankingnews.com - April 14 at 1:44 AM
Merit Medical Systems (NASDAQ:MMSI) Stock Rating Reaffirmed by Needham & Company LLCMerit Medical Systems (NASDAQ:MMSI) Stock Rating Reaffirmed by Needham & Company LLC
americanbankingnews.com - April 13 at 6:16 AM
Merit Medical Systems (NASDAQ:MMSI) Coverage Initiated at CL KingMerit Medical Systems (NASDAQ:MMSI) Coverage Initiated at CL King
americanbankingnews.com - April 13 at 3:40 AM
StockNews.com Lowers Merit Medical Systems (NASDAQ:MMSI) to HoldStockNews.com Lowers Merit Medical Systems (NASDAQ:MMSI) to Hold
marketbeat.com - April 12 at 11:17 PM
Decoding 7 Analyst Evaluations For Merit Medical SystemsDecoding 7 Analyst Evaluations For Merit Medical Systems
markets.businessinsider.com - April 11 at 3:43 PM
Needham & Company LLC Reiterates Buy Rating for Merit Medical Systems (NASDAQ:MMSI)Needham & Company LLC Reiterates Buy Rating for Merit Medical Systems (NASDAQ:MMSI)
marketbeat.com - April 11 at 8:31 AM
Merit Medical Systems (NASDAQ:MMSI) Now Covered by CL KingMerit Medical Systems (NASDAQ:MMSI) Now Covered by CL King
marketbeat.com - April 11 at 8:12 AM
Merit Medical Systems (MMSI) Poised for Growth: Buy Rating Affirmed on Strategic Initiatives and New Product LaunchMerit Medical Systems (MMSI) Poised for Growth: Buy Rating Affirmed on Strategic Initiatives and New Product Launch
markets.businessinsider.com - April 10 at 11:26 PM
Heres Why You Should Retain Merit Medical (MMSI) Stock for NowHere's Why You Should Retain Merit Medical (MMSI) Stock for Now
zacks.com - April 10 at 10:36 AM
Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of "Moderate Buy" by AnalystsMerit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of "Moderate Buy" by Analysts
americanbankingnews.com - April 10 at 2:30 AM
Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Rating of "Moderate Buy" by AnalystsMerit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Rating of "Moderate Buy" by Analysts
marketbeat.com - April 10 at 2:29 AM
Raymond James & Associates Decreases Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)Raymond James & Associates Decreases Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)
marketbeat.com - April 6 at 4:24 AM
What Is Merit Medical Systems, Inc.s (NASDAQ:MMSI) Share Price Doing?What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?
finance.yahoo.com - April 3 at 3:43 PM
BDX vs. MMSI: Which Stock Is the Better Value Option?BDX vs. MMSI: Which Stock Is the Better Value Option?
zacks.com - April 3 at 12:41 PM
Redwood Investments LLC Has $4.13 Million Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)Redwood Investments LLC Has $4.13 Million Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)
marketbeat.com - April 1 at 6:38 AM
Merit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?Merit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 29 at 4:10 PM
Heres Why Merit Medical (MMSI) is a Strong Value StockHere's Why Merit Medical (MMSI) is a Strong Value Stock
zacks.com - March 27 at 10:46 AM
Fort Washington Investment Advisors Inc. OH Sells 56,640 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)Fort Washington Investment Advisors Inc. OH Sells 56,640 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
marketbeat.com - March 27 at 6:31 AM
MMSI Oct 2024 50.000 putMMSI Oct 2024 50.000 put
finance.yahoo.com - March 25 at 12:40 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Atrion logo

Atrion

NASDAQ:ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Haemonetics logo

Haemonetics

NYSE:HAE
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Merit Medical Systems logo

Merit Medical Systems

NASDAQ:MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.